nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Avoidable waste in the production and reporting of research evidence
|
Chalmers, Iain |
|
2009 |
374 |
9683 |
p. 86-89 4 p. |
artikel |
2 |
Buried data and the UK Healthcare Commission's legacy
|
Sherlaw-Johnson, Chris |
|
2009 |
374 |
9683 |
p. 27- 1 p. |
artikel |
3 |
Crisis in the Swat Valley of Pakistan: need for international action
|
Bile, KM |
|
2009 |
374 |
9683 |
p. 23- 1 p. |
artikel |
4 |
Crisis in the Swat Valley of Pakistan: need for international action
|
Chotani, Rashid A |
|
2009 |
374 |
9683 |
p. 23-24 2 p. |
artikel |
5 |
Department of Error
|
|
|
2009 |
374 |
9683 |
p. 28- 1 p. |
artikel |
6 |
Department of Error
|
|
|
2009 |
374 |
9683 |
p. 28- 1 p. |
artikel |
7 |
Dietary fibre: refining a definition
|
Harris, Suzanne S |
|
2009 |
374 |
9683 |
p. 28- 1 p. |
artikel |
8 |
End to whaling ban?
|
Maumi, Gurbinder |
|
2009 |
374 |
9683 |
p. 12- 1 p. |
artikel |
9 |
GLP-1 receptor agonists for type 2 diabetes
|
De Block, Christophe EM |
|
2009 |
374 |
9683 |
p. 4-6 3 p. |
artikel |
10 |
G8 Summit 2009: what approach will Italy take to health?
|
Missoni, Eduardo |
|
2009 |
374 |
9683 |
p. 9-10 2 p. |
artikel |
11 |
Healthy spaces
|
Mitchell, Richard |
|
2009 |
374 |
9683 |
p. 18- 1 p. |
artikel |
12 |
Indigenous health part 1: determinants and disease patterns
|
Gracey, Michael |
|
2009 |
374 |
9683 |
p. 65-75 11 p. |
artikel |
13 |
Indigenous health part 2: the underlying causes of the health gap
|
King, Malcolm |
|
2009 |
374 |
9683 |
p. 76-85 10 p. |
artikel |
14 |
Jails, justice, and public health
|
Freudenberg, Nicholas |
|
2009 |
374 |
9683 |
p. 17-18 2 p. |
artikel |
15 |
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
|
Buse, John B |
|
2009 |
374 |
9683 |
p. 39-47 9 p. |
artikel |
16 |
Long-term outcome of placental-site trophoblastic tumours
|
Kohorn, Ernest I |
|
2009 |
374 |
9683 |
p. 6-7 2 p. |
artikel |
17 |
Loss of land could threaten health of Sámi people
|
Morris, Kelly |
|
2009 |
374 |
9683 |
p. 15-16 2 p. |
artikel |
18 |
Marlene Kong: one of Australia's few Indigenous doctors
|
Shetty, Priya |
|
2009 |
374 |
9683 |
p. 19- 1 p. |
artikel |
19 |
NECT trial: more than a small victory over sleeping sickness
|
Opigo, Jimmy |
|
2009 |
374 |
9683 |
p. 7-9 3 p. |
artikel |
20 |
Neuroleptic malignant syndrome versus malignant disease: idiosyncratic or synchronous?
|
Shintani, Futoshi |
|
2009 |
374 |
9683 |
p. 90- 1 p. |
artikel |
21 |
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
|
Priotto, Gerardo |
|
2009 |
374 |
9683 |
p. 56-64 9 p. |
artikel |
22 |
Pakistan's refugees face uncertain future
|
Rashid, Audil |
|
2009 |
374 |
9683 |
p. 13-14 2 p. |
artikel |
23 |
Prepared for a ‘flu pandemic? I don't think so…
|
Baker, Sarah |
|
2009 |
374 |
9683 |
p. 27-28 2 p. |
artikel |
24 |
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
|
Schmid, Peter |
|
2009 |
374 |
9683 |
p. 48-55 8 p. |
artikel |
25 |
Rivaroxaban in acute coronary syndromes: too soon to know?
|
Gurm, Hitinder S |
|
2009 |
374 |
9683 |
p. 3-4 2 p. |
artikel |
26 |
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
|
Mega, JL |
|
2009 |
374 |
9683 |
p. 29-38 10 p. |
artikel |
27 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial
|
Danchin, Nicolas |
|
2009 |
374 |
9683 |
p. 24-25 2 p. |
artikel |
28 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial
|
Bloom, Jeffrey M |
|
2009 |
374 |
9683 |
p. 25-26 2 p. |
artikel |
29 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial
|
Sniderman, Allan D |
|
2009 |
374 |
9683 |
p. 25- 1 p. |
artikel |
30 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial
|
Rosenstein, Robert |
|
2009 |
374 |
9683 |
p. 25- 1 p. |
artikel |
31 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial
|
de Tena, Jaime García |
|
2009 |
374 |
9683 |
p. 24- 1 p. |
artikel |
32 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial
|
Segura, J |
|
2009 |
374 |
9683 |
p. 26- 1 p. |
artikel |
33 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial
|
Feeman Jr, WE |
|
2009 |
374 |
9683 |
p. 24- 1 p. |
artikel |
34 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial – Authors' reply
|
Ridker, Paul M |
|
2009 |
374 |
9683 |
p. 26-27 2 p. |
artikel |
35 |
Strengthening research capacity in Africa
|
The Lancet, |
|
2009 |
374 |
9683 |
p. 1- 1 p. |
artikel |
36 |
Turkan Saylan
|
Solberg, Kristin |
|
2009 |
374 |
9683 |
p. 22- 1 p. |
artikel |
37 |
UK falling behind on cancer care
|
The Lancet, |
|
2009 |
374 |
9683 |
p. 2- 1 p. |
artikel |
38 |
Venice statement: global health initiatives and health systems
|
|
|
2009 |
374 |
9683 |
p. 10-12 3 p. |
artikel |
39 |
Where are we now with Indigenous health?
|
The Lancet, |
|
2009 |
374 |
9683 |
p. 2- 1 p. |
artikel |
40 |
Writing values
|
Bolton, Gillie |
|
2009 |
374 |
9683 |
p. 20-21 2 p. |
artikel |